SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...

Treatment with high and low doses of rilzabrutinib resulted in 36% and 25% relative risk reduction in loss of asthma control events. Significant and clinically meaningful improvements in asthma ...

This new data was the result of a recent case-controlled study that aimed to assess the effects of a PDL that provides an exemption from out-of-pocket cost sharing for patients’ asthma medications on ...

Please provide your email address to receive an email when new articles are posted on . Pneumonia, hoarse voice and oral thrush were the greatest burdens with inhaled corticosteroids. Patients also ...

Oral corticosteroids, although effective, pose significant adverse effects and health care costs, necessitating clear tapering guidelines and alternative treatments. Biologics significantly reduce ...

Medications that target inflammation, such as immunotherapy and steroids, treat allergic asthma, a common type of asthma.

Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...

Explore the most influential drug approvals of 2025, highlighting FDA-cleared therapies that impact public health and clinical care.

Please provide your email address to receive an email when new articles are posted on . Mean Asthma Control Questionnaire-6 scores fell from 2.6 at baseline to 1.4 at week 52. 47.3% had partially or ...

Dear Dr. Roach: I’m a 55-year-old perimenopausal woman who developed asthma a few years ago. My symptoms always start right before my menstrual cycle. My doctor ruled out allergies as the cause. I ...

Medically reviewed by Corinne Savides Happel, MD Key Takeaways CPAP helps keep airways open and prevents breathing gaps ...

KT-621 demonstrated comparable or superior activity to dupilumab in reversing disease progression in a chronic asthma model, indicating its potential as an effective treatment option. Kymera ...